Guest guest Posted March 15, 2010 Report Share Posted March 15, 2010 http://www.theheart.org/article/1054543.do " Nilsson added that with the conclusion of the ACCORD study —which as well as this ACCORD BP trial included the ACCORD lipid trial, also reported here at the ACC meeting —a period of three landmark studies (UKPDS, ADVANCE, and ACCORD) has now come to an end. " We learn from the completed ACCORD study that flexible goals should probably be applied to the control of hyperglycemia, blood pressure, and dyslipidemia in patients with type 2 diabetes, taking into account individual clinical factors of importance, " he states. " basically these studies surprised the Medical community because they showed that lower blood sugar, lipids and BP are not better than *normal levels in diabetics. wonder if they will ever do any landmark studies on hypoT patients... -Carol ps= by their statement: taking into account individual clinical factors of importance it makes me think they will start making patietns individual Signs and symptosm and profile more important than a specific Lab test # goal Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.